Magic mushroom compound could ease bipolar depression in new trial
Symptom relief
Not yet recruiting
This study tests whether a single dose of psilocybin (25 mg), given with therapy, can reduce depression in people with bipolar II disorder who haven't improved with standard treatments. 90 adults aged 19-65 will receive either the full dose or a very low placebo dose, and their s…
Phase: PHASE3 • Sponsor: Lakshmi N Yatham • Aim: Symptom relief
Last updated May 10, 2026 16:09 UTC